Jun 25, 2026 Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets
Jun 4, 2026 Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization
May 4, 2026 Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
Apr 16, 2026 Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
Apr 14, 2026 Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results
